Clinical Trial

KOrean Borderline Ovarian Tumor (KOBOT) Registry

Name: KOrean Borderline Ovarian Tumor (KOBOT) Registry — clinical trial record (NCT02803970)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KOBOT

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2016-06-14; most recent amendment 2019-04-01.

Trial Details

NCT Number	NCT02803970
Lead Sponsor	Kangbuk Samsung Hospital
Conditions	Ovarian Neoplasms
Enrollment	3,000 participants
Start Date	1994-12
Primary Completion	2040-12 (estimated)
Study Completion	2040-12 (estimated)
Updated on ClinicalTrials.gov	2019-04-03